Effects of anti-CD14 mAba
Additors During Priming . | DNA Synthesis (cpm/Culture) . |
---|---|
LPS | 8932 ± 247 |
Anti-CD14 mAb MEM-18 + LPS | 564 ± 139 |
TT | 3921 ± 210 |
Anti-CD14 mAb MEM-18 + TT | 3942 ± 354 |
SEB | 7954 ± 467 |
Anti-CD14 mAb MEM-18 + SEB | 8621 ± 1087 |
Medium control | 231 ± 43 |
Anti-CD14 mAb MEM-18 + medium control | 198 ± 23 |
Additors During Priming . | DNA Synthesis (cpm/Culture) . |
---|---|
LPS | 8932 ± 247 |
Anti-CD14 mAb MEM-18 + LPS | 564 ± 139 |
TT | 3921 ± 210 |
Anti-CD14 mAb MEM-18 + TT | 3942 ± 354 |
SEB | 7954 ± 467 |
Anti-CD14 mAb MEM-18 + SEB | 8621 ± 1087 |
Medium control | 231 ± 43 |
Anti-CD14 mAb MEM-18 + medium control | 198 ± 23 |
Purified monocytes were preincubated with or without anti-CD14 mAb MEM-18 and then primed LPS, TT, or SEB for 1 h. For further details, see Materials and Methods. These primed monocytes (1 × 105/ml) were added to purified autologous T lymphocytes (1 × 106/ml). DNA synthesis was measured after 4 days in SEB-stimulated cultures or after 7 days in LPS, TT, or unstimulated cultures, respectively. Data are expressed as mean ± SD of three parallel cultures.